Journal Article
[Evaluation of health-related quality of life in patients with non-Hodgkin lymphoma and colorectal cancer at different stages, attending the Mexican Institute of Social Security]
Fecha
2011Registro en:
1524-4733; 1098-3015
10.1016/j.jval.2011.05.031
Autor
Balderas-Pena LM
Sat-Munoz D
Contreras-Hernandez I
Solano-Murillo P
Hernandez-Chavez GA
Mariscal-Ramirez I
Lomeli-Garcia M
Diaz-Cortes MA
Mould-Quevedo JF
Palomares-Chacon U
Balderas-Pena CA
Garces-Ruiz OM
Morgan-Villela G
Institución
Resumen
INTRODUCTION: In Mexico during 2008, were reported 127,604 new cancer cases, 6,347 of them were colorectal cancer cases and 4,276 non-Hodgkin lymphoma (NHL) cases. OBJECTIVE: To evaluate health related quality of life in non-Hodgkin lymphoma and colorectal cancer cases in different clinical stages, attended in a High Specialty Medical facility at the Instituto Mexicano del Seguro Social, during a 13 month period. RESULTS: 162 patients were included, 56.8% (n=92) with NHL and 43.2% (n=70) with colorectal cancer. The scores obtained in the NHL group were: Global health status/QoL: 67.75 (+/- 27.55), physical functioning 69.64 (+/- 29.98), role functioning 71.38 (+/- 33.73), emotional functioning 69.7 (+/- 26.57), cognitive functioning 75.36 (+/- 28.01), social functioning 79.35 (+/- 29.38), fatigue 35.27 (+/- 28.27), nausea and vomiting 13.41 (+/- 21.85), pain 28.08 (+/- 30.25), dyspnea 19.20 (+/- 32.11), insomnia 30.80 (+/- 38.03), appetite lost 26.45 (+/- 36.16), constipation 19.20 (+/- 32.11), diarrhea 12.32 (+/- 26.48), financial difficulties 26.09 (+/- 35.57). In colorectal cancer patients the scores were: Global health status/QoL: 68.21 (+/- 24.46), physical functioning 67.38 (+/- 30.45), role functioning 65.48 (+/- 35.70), emotional functioning 66.43 (+/- 26.84), cognitive functioning 78.57 (+/- 26.49), social functioning 75.24 (+/- 31.05), fatigue 37.78 (+/- 31.62), nausea and vomiting 20.00 (+/- 28.32), pain 37.38 (+/- 34.45), dyspnea 11.90 (+/- 26.64), insomnia 28.09 (+/- 35.73), appetite lost 23.81 (+/- 36.40), constipation 19.05 (+/- 32.88), diarrhea 20.95 (+/- 31.17), financial difficulties 34.76 (+/- 38.67). CONCLUSIONS: With these basal results is important a follow-up with special attention to the treatment and attendance processes, in patients with this neoplasms and their impact on the quality of life.Copyright ?� 2011 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.